{"transactions":[{"id":749425,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-04T21:22:50.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":223492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":223492,"derivative":{"exercise_price":1.58,"exercise_date":"2026-07-03","expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":223492},"source":{"system":"sec-edgar","filing":"0001299130-26-000098","document":"wk-form4_1780608167.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913026000098/wk-form4_1780608167.xml","form_type":"4"}},{"id":1119427,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-06T20:08:16.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":65000,"derivative":{"exercise_price":1.03,"exercise_date":"2025-07-04","expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001299130-25-000134","document":"wk-form4_1749240489.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913025000134/wk-form4_1749240489.xml","form_type":"4"}},{"id":1472999,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-20T20:52:01.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":32179,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":32179,"derivative":{"exercise_price":1.65,"exercise_date":"2024-07-18","expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":32179},"source":{"system":"sec-edgar","filing":"0001299130-24-000149","document":"wk-form4_1718916715.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913024000149/wk-form4_1718916715.xml","form_type":"4"}},{"id":1472998,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-20T20:52:01.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":22821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\"). The RSUs will vest on the one (1) year anniversary of the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":41616,"source":{"system":"sec-edgar","filing":"0001299130-24-000149","document":"wk-form4_1718916715.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913024000149/wk-form4_1718916715.xml","form_type":"4"}},{"id":1876289,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-26T20:30:12.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":25775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":25775,"derivative":{"exercise_price":11.94,"exercise_date":"2023-06-24","expiration_date":"2033-05-24","underlying":"Common Stock","underlying_shares":25775},"source":{"system":"sec-edgar","filing":"0001299130-23-000074","document":"wf-form4_168513293547338.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913023000074/wf-form4_168513293547338.xml","form_type":"4"}},{"id":1946624,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-17T21:31:54.000Z","date":"2023-03-15","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":2.54,"expiration_date":"2023-05-21","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001299130-23-000044","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913023000044/certent-form4.xml","form_type":"4"}},{"id":1946623,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-17T21:31:54.000Z","date":"2023-03-15","kind":"sale","acquired":false,"shares":7541,"price":8.9,"value":67114.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the exercise price of soon-to-expire stock options."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This sale price represents the weighted average sale price of the shares sold ranging from $8.84 to $8.93 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":18795,"source":{"system":"sec-edgar","filing":"0001299130-23-000044","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913023000044/certent-form4.xml","form_type":"4"}},{"id":1946622,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-17T21:31:54.000Z","date":"2023-03-15","kind":"exercise","acquired":true,"shares":25000,"price":2.54,"value":63500.0,"ownership":{"direct":true},"balance_after":26336,"source":{"system":"sec-edgar","filing":"0001299130-23-000044","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913023000044/certent-form4.xml","form_type":"4"}},{"id":2253098,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-27T23:20:41.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":63015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":63015,"derivative":{"exercise_price":5.37,"exercise_date":"2022-06-25","expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":63015},"source":{"system":"sec-edgar","filing":"0001299130-22-000077","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913022000077/certent-form4.xml","form_type":"4"}},{"id":2297630,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-14T01:26:01.000Z","date":"2022-03-17","kind":"other","acquired":true,"shares":1268,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Distribution in kind from MDV VII Leaders' Fund, L.P., MDV VII, L.P., MDV ENF VII(A), L.P, and MDV ENF VII(B), L.P., without consideration to their partners."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Distribution in kind from MDV VII Leaders' Fund, L.P., MDV VII, L.P., MDV ENF VII(A), L.P, and MDV ENF VII(B), L.P., without consideration to their partners."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares are directly held by William Ericson, and were received pursuant to the in-kind distribution without consideration by MDV VII Leaders' Fund, L.P. to its partners."}],"balance_after":1336,"source":{"system":"sec-edgar","filing":"0000899243-22-014756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000089924322014756/doc4.xml","form_type":"4"}},{"id":2297629,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-14T01:26:01.000Z","date":"2022-03-17","kind":"other","acquired":false,"shares":4848397,"ownership":{"direct":false,"nature":"MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Distribution in kind from MDV VII Leaders' Fund, L.P., MDV VII, L.P., MDV ENF VII(A), L.P, and MDV ENF VII(B), L.P., without consideration to their partners."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Distribution in kind from MDV VII Leaders' Fund, L.P., MDV VII, L.P., MDV ENF VII(A), L.P, and MDV ENF VII(B), L.P., without consideration to their partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV VII Leaders' Fund, L.P., MDV ENF VII(A), L.P, and MDV ENF VII(B), L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII(A), L.P., (iv) MDV ENF VII(B), L.P. and (v) MDV VII Leaders' Fund, L.P. (the \"MDV VII Funds\") and has sole voting and investment power over the shares. William Ericson is a Managing director with Mohr Davidow Ventures, but is not a Managing Member of Seventh MDV Partners, LLC, however he may be deemed to indirectly beneficially own the shares affiliated with the MDV VII Funds. Mr. Ericson disclaims beneficial ownership of the shares held by the MDV VII Funds except to the extent of any pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-014756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000089924322014756/doc4.xml","form_type":"4"}},{"id":2297628,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-14T01:26:01.000Z","date":"2021-02-12","kind":"other","acquired":true,"shares":68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution in kind from MDV VII Leaders' Fund, L.P. and MDV VII, L.P. without consideration to their partners."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution in kind from MDV VII Leaders' Fund, L.P. and MDV VII, L.P. without consideration to their partners."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares are directly held by William Ericson, and were received pursuant to the in-kind distribution without consideration by MDV VII Leaders' Fund, L.P. and MDV VII, L.P.  to their partners."}],"balance_after":68,"source":{"system":"sec-edgar","filing":"0000899243-22-014756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000089924322014756/doc4.xml","form_type":"4"}},{"id":2297627,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-14T01:26:01.000Z","date":"2021-02-12","kind":"other","acquired":false,"shares":750000,"ownership":{"direct":false,"nature":"MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution in kind from MDV VII Leaders' Fund, L.P. and MDV VII, L.P. without consideration to their partners."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution in kind from MDV VII Leaders' Fund, L.P. and MDV VII, L.P. without consideration to their partners."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares were inadvertently omitted as a holding on a Form 4 filed on June 21, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV VII Leaders' Fund, L.P., MDV ENF VII(A), L.P, and MDV ENF VII(B), L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII(A), L.P., (iv) MDV ENF VII(B), L.P. and (v) MDV VII Leaders' Fund, L.P. (the \"MDV VII Funds\") and has sole voting and investment power over the shares. William Ericson is a Managing director with Mohr Davidow Ventures, but is not a Managing Member of Seventh MDV Partners, LLC, however he may be deemed to indirectly beneficially own the shares affiliated with the MDV VII Funds. Mr. Ericson disclaims beneficial ownership of the shares held by the MDV VII Funds except to the extent of any pecuniary interest therein."}],"balance_after":4848397,"source":{"system":"sec-edgar","filing":"0000899243-22-014756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000089924322014756/doc4.xml","form_type":"4"}},{"id":2494935,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-24T16:09:56.000Z","date":"2021-11-24","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"$2.89 plus two CVRs per share underlying the stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and with a per share exercise price less than $8.10, was cancelled at the Effective Time and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, two CVRs plus the excess of (i) $8.10 over (ii) the per share exercise price of such Issuer option."}],"balance_after":0,"derivative":{"exercise_price":5.21,"exercise_date":"2022-06-02","expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001328143-21-000091","document":"wf-form4_163778817985401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000132814321000091/wf-form4_163778817985401.xml","form_type":"4"}},{"id":2494934,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-24T16:09:56.000Z","date":"2021-11-24","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"$5.40 plus two CVRs per share underlying the stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option is fully vested and exercisable."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and with a per share exercise price less than $8.10, was cancelled at the Effective Time and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, two CVRs plus the excess of (i) $8.10 over (ii) the per share exercise price of such Issuer option."}],"balance_after":0,"derivative":{"exercise_price":2.7,"expiration_date":"2030-06-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001328143-21-000091","document":"wf-form4_163778817985401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000132814321000091/wf-form4_163778817985401.xml","form_type":"4"}},{"id":2494933,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-24T16:09:56.000Z","date":"2021-11-24","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"$3.30 plus two CVRs per share underlying the stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option is fully vested and exercisable."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and with a per share exercise price less than $8.10, was cancelled at the Effective Time and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, two CVRs plus the excess of (i) $8.10 over (ii) the per share exercise price of such Issuer option."}],"balance_after":0,"derivative":{"exercise_price":4.8,"expiration_date":"2029-06-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001328143-21-000091","document":"wf-form4_163778817985401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000132814321000091/wf-form4_163778817985401.xml","form_type":"4"}},{"id":2494932,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T16:09:56.000Z","date":"2021-11-24","kind":"other","acquired":false,"shares":265150,"ownership":{"direct":false,"nature":"MDV VII, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 10, 2021, by and among the Issuer, Supernus Pharmaceuticals, Inc. (\"Parent\") and Supernus Reef, Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of November 24, 2021 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $8.10 in cash plus two contingent value rights (\"CVRs\" and, collectively with the cash amount, the \"Per Share Price\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Disposed of pursuant to Merger Agreement in exchange for $8.10 plus two CVRs per share. The CVRs do not have a market value."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV ENF VII(A), L.P., MDV ENF VII(B), L.P., and MDV VII Leaders' Fund, L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII(A), L.P., (iv) MDV ENF VII(B), L.P., and (v) MDV VII Leaders' Fund, L.P. (collectively, \"MDV VII\"). Feiber and Nancy Schoendorf (\"Schoendorf\") are Managing Members of Seventh MDV Partners, L.L.C. Feiber and Schoendorf may be deemed to share voting and dispositive power over the shares held by MDV VII. Each Reporting Person disclaims beneficial ownership of the shares held by MDV VII except to the extent of any pecuniary interest therein. Ericson, a general partner with Mohr Davidow Ventures, may be deemed to indirectly beneficially own the shares affiliated with MDV VII. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001328143-21-000091","document":"wf-form4_163778817985401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000132814321000091/wf-form4_163778817985401.xml","form_type":"4"}},{"id":2494931,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T16:09:56.000Z","date":"2021-11-24","kind":"other","acquired":false,"shares":287992,"ownership":{"direct":false,"nature":"MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 10, 2021, by and among the Issuer, Supernus Pharmaceuticals, Inc. (\"Parent\") and Supernus Reef, Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of November 24, 2021 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $8.10 in cash plus two contingent value rights (\"CVRs\" and, collectively with the cash amount, the \"Per Share Price\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Disposed of pursuant to Merger Agreement in exchange for $8.10 plus two CVRs per share. The CVRs do not have a market value."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Ninth MDV Partners, L.L.C. is the general partner of MDV IX, L.P., as nominee for MDV IX, L.P. and MDV ENF IX, L.P. (collectively, \"MDV IX\"). William Ericson (\"Ericson\") and Jonathan Feiber (\"Feiber\") are Managing Members of Ninth MDV Partners, L.L.C. Ericson and Feiber may be deemed to share voting and dispositive power over the shares held by MDV IX. Each Reporting Person disclaims beneficial ownership of the shares held by MDV IX except to the extent of any pecuniary interest therein. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001328143-21-000091","document":"wf-form4_163778817985401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000132814321000091/wf-form4_163778817985401.xml","form_type":"4"}},{"id":2494930,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T16:09:56.000Z","date":"2021-11-24","kind":"other","acquired":false,"shares":25661,"ownership":{"direct":false,"nature":"MDV VII Leaders' Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 10, 2021, by and among the Issuer, Supernus Pharmaceuticals, Inc. (\"Parent\") and Supernus Reef, Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of November 24, 2021 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $8.10 in cash plus two contingent value rights (\"CVRs\" and, collectively with the cash amount, the \"Per Share Price\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Disposed of pursuant to Merger Agreement in exchange for $8.10 plus two CVRs per share. The CVRs do not have a market value."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV ENF VII(A), L.P., MDV ENF VII(B), L.P., and MDV VII Leaders' Fund, L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII(A), L.P., (iv) MDV ENF VII(B), L.P., and (v) MDV VII Leaders' Fund, L.P. (collectively, \"MDV VII\"). Feiber and Nancy Schoendorf (\"Schoendorf\") are Managing Members of Seventh MDV Partners, L.L.C. Feiber and Schoendorf may be deemed to share voting and dispositive power over the shares held by MDV VII. Each Reporting Person disclaims beneficial ownership of the shares held by MDV VII except to the extent of any pecuniary interest therein. Ericson, a general partner with Mohr Davidow Ventures, may be deemed to indirectly beneficially own the shares affiliated with MDV VII. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001328143-21-000091","document":"wf-form4_163778817985401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000132814321000091/wf-form4_163778817985401.xml","form_type":"4"}},{"id":2494929,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T16:09:56.000Z","date":"2021-11-24","kind":"other","acquired":false,"shares":3146,"ownership":{"direct":false,"nature":"MDV ENF VII (B), L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 10, 2021, by and among the Issuer, Supernus Pharmaceuticals, Inc. (\"Parent\") and Supernus Reef, Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of November 24, 2021 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $8.10 in cash plus two contingent value rights (\"CVRs\" and, collectively with the cash amount, the \"Per Share Price\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Disposed of pursuant to Merger Agreement in exchange for $8.10 plus two CVRs per share. The CVRs do not have a market value."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV ENF VII(A), L.P., MDV ENF VII(B), L.P., and MDV VII Leaders' Fund, L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII(A), L.P., (iv) MDV ENF VII(B), L.P., and (v) MDV VII Leaders' Fund, L.P. (collectively, \"MDV VII\"). Feiber and Nancy Schoendorf (\"Schoendorf\") are Managing Members of Seventh MDV Partners, L.L.C. Feiber and Schoendorf may be deemed to share voting and dispositive power over the shares held by MDV VII. Each Reporting Person disclaims beneficial ownership of the shares held by MDV VII except to the extent of any pecuniary interest therein. Ericson, a general partner with Mohr Davidow Ventures, may be deemed to indirectly beneficially own the shares affiliated with MDV VII. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001328143-21-000091","document":"wf-form4_163778817985401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000132814321000091/wf-form4_163778817985401.xml","form_type":"4"}},{"id":2494928,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T16:09:56.000Z","date":"2021-11-24","kind":"other","acquired":false,"shares":6043,"ownership":{"direct":false,"nature":"MDV ENF VII (A), L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 10, 2021, by and among the Issuer, Supernus Pharmaceuticals, Inc. (\"Parent\") and Supernus Reef, Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of November 24, 2021 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $8.10 in cash plus two contingent value rights (\"CVRs\" and, collectively with the cash amount, the \"Per Share Price\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Disposed of pursuant to Merger Agreement in exchange for $8.10 plus two CVRs per share. The CVRs do not have a market value."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV ENF VII(A), L.P., MDV ENF VII(B), L.P., and MDV VII Leaders' Fund, L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII(A), L.P., (iv) MDV ENF VII(B), L.P., and (v) MDV VII Leaders' Fund, L.P. (collectively, \"MDV VII\"). Feiber and Nancy Schoendorf (\"Schoendorf\") are Managing Members of Seventh MDV Partners, L.L.C. Feiber and Schoendorf may be deemed to share voting and dispositive power over the shares held by MDV VII. Each Reporting Person disclaims beneficial ownership of the shares held by MDV VII except to the extent of any pecuniary interest therein. Ericson, a general partner with Mohr Davidow Ventures, may be deemed to indirectly beneficially own the shares affiliated with MDV VII. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001328143-21-000091","document":"wf-form4_163778817985401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000132814321000091/wf-form4_163778817985401.xml","form_type":"4"}},{"id":2494927,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T16:09:56.000Z","date":"2021-11-24","kind":"other","acquired":false,"shares":4031804,"ownership":{"direct":false,"nature":"MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 10, 2021, by and among the Issuer, Supernus Pharmaceuticals, Inc. (\"Parent\") and Supernus Reef, Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of November 24, 2021 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $8.10 in cash plus two contingent value rights (\"CVRs\" and, collectively with the cash amount, the \"Per Share Price\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Disposed of pursuant to Merger Agreement in exchange for $8.10 plus two CVRs per share. The CVRs do not have a market value."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV ENF VII(A), L.P., MDV ENF VII(B), L.P., and MDV VII Leaders' Fund, L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII(A), L.P., (iv) MDV ENF VII(B), L.P., and (v) MDV VII Leaders' Fund, L.P. (collectively, \"MDV VII\"). Feiber and Nancy Schoendorf (\"Schoendorf\") are Managing Members of Seventh MDV Partners, L.L.C. Feiber and Schoendorf may be deemed to share voting and dispositive power over the shares held by MDV VII. Each Reporting Person disclaims beneficial ownership of the shares held by MDV VII except to the extent of any pecuniary interest therein. Ericson, a general partner with Mohr Davidow Ventures, may be deemed to indirectly beneficially own the shares affiliated with MDV VII. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001328143-21-000091","document":"wf-form4_163778817985401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000132814321000091/wf-form4_163778817985401.xml","form_type":"4"}},{"id":2494926,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T16:09:56.000Z","date":"2021-11-24","kind":"other","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 10, 2021, by and among the Issuer, Supernus Pharmaceuticals, Inc. (\"Parent\") and Supernus Reef, Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of November 24, 2021 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $8.10 in cash plus two contingent value rights (\"CVRs\" and, collectively with the cash amount, the \"Per Share Price\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"A portion of this amount consists of unvested restricted stock units (\"RSUs\"). Pursuant to the terms of the Merger Agreement, each Issuer RSU that was outstanding immediately prior to the Effective Time was cancelled at the Effective Time and automatically converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding under applicable tax law, the Per Share Price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Disposed of pursuant to Merger Agreement in exchange for $8.10 plus two CVRs per share. The CVRs do not have a market value."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001328143-21-000091","document":"wf-form4_163778817985401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000132814321000091/wf-form4_163778817985401.xml","form_type":"4"}},{"id":2660674,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-22T01:15:50.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":12885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one year period, or, if earlier, on the date of the next annual meeting of stockholders, provided the Reporting Person continues to serve as a director through each vesting date."}],"balance_after":12885,"derivative":{"exercise_price":27.9,"exercise_date":"2021-07-16","expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":12885},"source":{"system":"sec-edgar","filing":"0001299130-21-000172","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913021000172/certent-form4.xml","form_type":"4"}},{"id":2680580,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-04T16:14:14.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Option shares vest in full on the one year anniversary of the grant date, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of such date."}],"balance_after":10000,"derivative":{"exercise_price":5.21,"exercise_date":"2022-06-02","expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001328143-21-000057","document":"wf-form4_162283764024247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000132814321000057/wf-form4_162283764024247.xml","form_type":"4"}},{"id":2680579,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-04T16:14:14.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest on the one year anniversary of the grant date, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of such date."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001328143-21-000057","document":"wf-form4_162283764024247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000132814321000057/wf-form4_162283764024247.xml","form_type":"4"}},{"id":2694913,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-27T00:50:42.000Z","date":"2021-05-25","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.83,"expiration_date":"2022-06-13","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001299130-21-000152","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913021000152/certent-form4.xml","form_type":"4"}},{"id":2694912,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-27T00:50:42.000Z","date":"2021-05-25","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":10.58,"expiration_date":"2021-06-23","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001299130-21-000152","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913021000152/certent-form4.xml","form_type":"4"}},{"id":2694911,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T00:50:42.000Z","date":"2021-05-25","kind":"sale","acquired":false,"shares":900,"price":26.419,"value":23777.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 18, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This sale price represents the weighted average sale price of the shares sold ranging from $26.37 to $26.43 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001299130-21-000152","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913021000152/certent-form4.xml","form_type":"4"}},{"id":2694910,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T00:50:42.000Z","date":"2021-05-25","kind":"sale","acquired":false,"shares":36600,"price":25.882,"value":947281.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 18, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This sale price represents the weighted average sale price of the shares sold ranging from $25.37 to $26.36 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":900,"source":{"system":"sec-edgar","filing":"0001299130-21-000152","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913021000152/certent-form4.xml","form_type":"4"}},{"id":2694909,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T00:50:42.000Z","date":"2021-05-25","kind":"exercise","acquired":true,"shares":25000,"price":1.83,"value":45750.0,"ownership":{"direct":true},"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001299130-21-000152","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913021000152/certent-form4.xml","form_type":"4"}},{"id":2694908,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T00:50:42.000Z","date":"2021-05-25","kind":"exercise","acquired":true,"shares":12500,"price":10.58,"value":132250.0,"ownership":{"direct":true},"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001299130-21-000152","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913021000152/certent-form4.xml","form_type":"4"}},{"id":3065764,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-08-06T22:43:06.000Z","date":"2020-08-04","kind":"grant","acquired":true,"shares":97785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one year period, or if earlier, on the date of the Issuer's next annual meeting of stockholders, provided that the Reporting Person continues to serve as a director through each vesting date."}],"balance_after":97785,"derivative":{"exercise_price":3.89,"exercise_date":"2020-09-04","expiration_date":"2030-08-04","underlying":"Common Stock","underlying_shares":97785},"source":{"system":"sec-edgar","filing":"0001209191-20-045568","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000120919120045568/doc4.xml","form_type":"4"}},{"id":3120018,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-05T19:42:51.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Option shares shall vest as follows: 100% of the option shares shall vest on the date 1 year from June 3, 2020, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of such date."}],"balance_after":10000,"derivative":{"exercise_price":2.7,"expiration_date":"2030-06-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-034864","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919120034864/doc4.xml","form_type":"4"}},{"id":3120017,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-05T19:42:51.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest on the date 1 year from June 3, 2020, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of such date."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-20-034864","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919120034864/doc4.xml","form_type":"4"}},{"id":3478228,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":156473,"kind":"organization","name":"Ninth MDV Partners, L.L.C.","position":1,"cik":"0001573991","reported_name":"Ninth MDV Partners, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156474,"kind":"organization","name":"MDV IX LP","position":2,"cik":"0001410787","reported_name":"MDV IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156475,"kind":"organization","name":"MDV ENF IX LP","position":3,"cik":"0001435083","reported_name":"MDV ENF IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135893,"kind":"person","name":"FEIBER JONATHAN D","position":4,"cik":"0001027621","reported_name":"FEIBER JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41306,"kind":"person","name":"Ericson William W.","position":5,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2019-06-26T16:54:22.000Z","date":"2019-06-24","kind":"exercise","acquired":false,"shares":127504,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held directly by MDV IX, L.P., as nominee for MDV IX, L.P. and MDV ENF IX, L.P. (\"IX Funds\"). Ninth MDV is the general partner of IX Funds. Jonathan Feiber and William Ericson are the managing members of Ninth MDV and either are deemed to have sole voting and dispositive power with respect to the shares held by IX Funds. Each disclaims beneficial ownership of these securities except to the extent of his or its respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":127504},"source":{"system":"sec-edgar","filing":"0001209191-19-039125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1027621/000120919119039125/doc4.xml","form_type":"4"}},{"id":3478227,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":156473,"kind":"organization","name":"Ninth MDV Partners, L.L.C.","position":1,"cik":"0001573991","reported_name":"Ninth MDV Partners, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156474,"kind":"organization","name":"MDV IX LP","position":2,"cik":"0001410787","reported_name":"MDV IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156475,"kind":"organization","name":"MDV ENF IX LP","position":3,"cik":"0001435083","reported_name":"MDV ENF IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135893,"kind":"person","name":"FEIBER JONATHAN D","position":4,"cik":"0001027621","reported_name":"FEIBER JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41306,"kind":"person","name":"Ericson William W.","position":5,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2019-06-26T16:54:22.000Z","date":"2019-06-24","kind":"exercise","acquired":false,"shares":504,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held directly by MDV ENF IX, L.P. (\"ENF IX\"). Ninth MDV is the general partner of ENF IX. Jonathan Feiber and William Ericson are the managing members of Ninth MDV and either are deemed to have sole voting and dispositive power with respect to the shares held by ENF IX. Each disclaims beneficial ownership of these securities except to the extent of his or its respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":504},"source":{"system":"sec-edgar","filing":"0001209191-19-039125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1027621/000120919119039125/doc4.xml","form_type":"4"}},{"id":3478226,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":156473,"kind":"organization","name":"Ninth MDV Partners, L.L.C.","position":1,"cik":"0001573991","reported_name":"Ninth MDV Partners, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156474,"kind":"organization","name":"MDV IX LP","position":2,"cik":"0001410787","reported_name":"MDV IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156475,"kind":"organization","name":"MDV ENF IX LP","position":3,"cik":"0001435083","reported_name":"MDV ENF IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135893,"kind":"person","name":"FEIBER JONATHAN D","position":4,"cik":"0001027621","reported_name":"FEIBER JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41306,"kind":"person","name":"Ericson William W.","position":5,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2019-06-26T16:54:22.000Z","date":"2019-06-24","kind":"exercise","acquired":false,"shares":61592,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by MDV IX, L.P. (\"MDV IX\"). Ninth MDV Partners, L.L.C. (\"Ninth MDV\") is the general partner of MDV IX. Jonathan Feiber and William Ericson are the managing members of Ninth MDV and either are deemed to have sole voting and dispositive power with respect to the shares held by MDV IX. Each disclaims beneficial ownership of these securities except to the extent of his or its respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":61592},"source":{"system":"sec-edgar","filing":"0001209191-19-039125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1027621/000120919119039125/doc4.xml","form_type":"4"}},{"id":3478225,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":156473,"kind":"organization","name":"Ninth MDV Partners, L.L.C.","position":1,"cik":"0001573991","reported_name":"Ninth MDV Partners, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156474,"kind":"organization","name":"MDV IX LP","position":2,"cik":"0001410787","reported_name":"MDV IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156475,"kind":"organization","name":"MDV ENF IX LP","position":3,"cik":"0001435083","reported_name":"MDV ENF IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135893,"kind":"person","name":"FEIBER JONATHAN D","position":4,"cik":"0001027621","reported_name":"FEIBER JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41306,"kind":"person","name":"Ericson William W.","position":5,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2019-06-26T16:54:22.000Z","date":"2019-06-24","kind":"exercise","acquired":false,"shares":882,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held directly by MDV ENF IX, L.P. (\"ENF IX\"). Ninth MDV is the general partner of ENF IX. Jonathan Feiber and William Ericson are the managing members of Ninth MDV and either are deemed to have sole voting and dispositive power with respect to the shares held by ENF IX. Each disclaims beneficial ownership of these securities except to the extent of his or its respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":882},"source":{"system":"sec-edgar","filing":"0001209191-19-039125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1027621/000120919119039125/doc4.xml","form_type":"4"}},{"id":3478224,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":156473,"kind":"organization","name":"Ninth MDV Partners, L.L.C.","position":1,"cik":"0001573991","reported_name":"Ninth MDV Partners, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156474,"kind":"organization","name":"MDV IX LP","position":2,"cik":"0001410787","reported_name":"MDV IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156475,"kind":"organization","name":"MDV ENF IX LP","position":3,"cik":"0001435083","reported_name":"MDV ENF IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135893,"kind":"person","name":"FEIBER JONATHAN D","position":4,"cik":"0001027621","reported_name":"FEIBER JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41306,"kind":"person","name":"Ericson William W.","position":5,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2019-06-26T16:54:22.000Z","date":"2019-06-24","kind":"exercise","acquired":false,"shares":107812,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by MDV IX, L.P. (\"MDV IX\"). Ninth MDV Partners, L.L.C. (\"Ninth MDV\") is the general partner of MDV IX. Jonathan Feiber and William Ericson are the managing members of Ninth MDV and either are deemed to have sole voting and dispositive power with respect to the shares held by MDV IX. Each disclaims beneficial ownership of these securities except to the extent of his or its respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":107812},"source":{"system":"sec-edgar","filing":"0001209191-19-039125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1027621/000120919119039125/doc4.xml","form_type":"4"}},{"id":3478223,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":156473,"kind":"organization","name":"Ninth MDV Partners, L.L.C.","position":1,"cik":"0001573991","reported_name":"Ninth MDV Partners, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156474,"kind":"organization","name":"MDV IX LP","position":2,"cik":"0001410787","reported_name":"MDV IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156475,"kind":"organization","name":"MDV ENF IX LP","position":3,"cik":"0001435083","reported_name":"MDV ENF IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135893,"kind":"person","name":"FEIBER JONATHAN D","position":4,"cik":"0001027621","reported_name":"FEIBER JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41306,"kind":"person","name":"Ericson William W.","position":5,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2019-06-26T16:54:22.000Z","date":"2019-06-24","kind":"exercise","acquired":false,"shares":18739,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held directly by MDV ENF IX, L.P. (\"ENF IX\"). Ninth MDV is the general partner of ENF IX. Jonathan Feiber and William Ericson are the managing members of Ninth MDV and either are deemed to have sole voting and dispositive power with respect to the shares held by ENF IX. Each disclaims beneficial ownership of these securities except to the extent of his or its respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":18739},"source":{"system":"sec-edgar","filing":"0001209191-19-039125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1027621/000120919119039125/doc4.xml","form_type":"4"}},{"id":3478222,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":156473,"kind":"organization","name":"Ninth MDV Partners, L.L.C.","position":1,"cik":"0001573991","reported_name":"Ninth MDV Partners, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156474,"kind":"organization","name":"MDV IX LP","position":2,"cik":"0001410787","reported_name":"MDV IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156475,"kind":"organization","name":"MDV ENF IX LP","position":3,"cik":"0001435083","reported_name":"MDV ENF IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135893,"kind":"person","name":"FEIBER JONATHAN D","position":4,"cik":"0001027621","reported_name":"FEIBER JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41306,"kind":"person","name":"Ericson William W.","position":5,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2019-06-26T16:54:22.000Z","date":"2019-06-24","kind":"exercise","acquired":false,"shares":2288805,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by MDV IX, L.P. (\"MDV IX\"). Ninth MDV Partners, L.L.C. (\"Ninth MDV\") is the general partner of MDV IX. Jonathan Feiber and William Ericson are the managing members of Ninth MDV and either are deemed to have sole voting and dispositive power with respect to the shares held by MDV IX. Each disclaims beneficial ownership of these securities except to the extent of his or its respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2288805},"source":{"system":"sec-edgar","filing":"0001209191-19-039125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1027621/000120919119039125/doc4.xml","form_type":"4"}},{"id":3478221,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":156473,"kind":"organization","name":"Ninth MDV Partners, L.L.C.","position":1,"cik":"0001573991","reported_name":"Ninth MDV Partners, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156474,"kind":"organization","name":"MDV IX LP","position":2,"cik":"0001410787","reported_name":"MDV IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156475,"kind":"organization","name":"MDV ENF IX LP","position":3,"cik":"0001435083","reported_name":"MDV ENF IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135893,"kind":"person","name":"FEIBER JONATHAN D","position":4,"cik":"0001027621","reported_name":"FEIBER JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41306,"kind":"person","name":"Ericson William W.","position":5,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-26T16:54:22.000Z","date":"2019-06-24","kind":"exercise","acquired":true,"shares":127504,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held directly by MDV IX, L.P., as nominee for MDV IX, L.P. and MDV ENF IX, L.P. (\"IX Funds\"). Ninth MDV is the general partner of IX Funds. Jonathan Feiber and William Ericson are the managing members of Ninth MDV and either are deemed to have sole voting and dispositive power with respect to the shares held by IX Funds. Each disclaims beneficial ownership of these securities except to the extent of his or its respective pecuniary interest therein."}],"balance_after":127504,"source":{"system":"sec-edgar","filing":"0001209191-19-039125","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1027621/000120919119039125/doc4.xml","form_type":"4"}},{"id":3478220,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":156473,"kind":"organization","name":"Ninth MDV Partners, L.L.C.","position":1,"cik":"0001573991","reported_name":"Ninth MDV Partners, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156474,"kind":"organization","name":"MDV IX LP","position":2,"cik":"0001410787","reported_name":"MDV IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156475,"kind":"organization","name":"MDV ENF IX LP","position":3,"cik":"0001435083","reported_name":"MDV ENF IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135893,"kind":"person","name":"FEIBER JONATHAN D","position":4,"cik":"0001027621","reported_name":"FEIBER JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41306,"kind":"person","name":"Ericson William W.","position":5,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-26T16:54:22.000Z","date":"2019-06-24","kind":"exercise","acquired":true,"shares":504,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held directly by MDV ENF IX, L.P. (\"ENF IX\"). Ninth MDV is the general partner of ENF IX. Jonathan Feiber and William Ericson are the managing members of Ninth MDV and either are deemed to have sole voting and dispositive power with respect to the shares held by ENF IX. Each disclaims beneficial ownership of these securities except to the extent of his or its respective pecuniary interest therein."}],"balance_after":20125,"source":{"system":"sec-edgar","filing":"0001209191-19-039125","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1027621/000120919119039125/doc4.xml","form_type":"4"}},{"id":3478219,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":156473,"kind":"organization","name":"Ninth MDV Partners, L.L.C.","position":1,"cik":"0001573991","reported_name":"Ninth MDV Partners, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156474,"kind":"organization","name":"MDV IX LP","position":2,"cik":"0001410787","reported_name":"MDV IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156475,"kind":"organization","name":"MDV ENF IX LP","position":3,"cik":"0001435083","reported_name":"MDV ENF IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135893,"kind":"person","name":"FEIBER JONATHAN D","position":4,"cik":"0001027621","reported_name":"FEIBER JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41306,"kind":"person","name":"Ericson William W.","position":5,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-26T16:54:22.000Z","date":"2019-06-24","kind":"exercise","acquired":true,"shares":882,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held directly by MDV ENF IX, L.P. (\"ENF IX\"). Ninth MDV is the general partner of ENF IX. Jonathan Feiber and William Ericson are the managing members of Ninth MDV and either are deemed to have sole voting and dispositive power with respect to the shares held by ENF IX. Each disclaims beneficial ownership of these securities except to the extent of his or its respective pecuniary interest therein."}],"balance_after":19621,"source":{"system":"sec-edgar","filing":"0001209191-19-039125","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1027621/000120919119039125/doc4.xml","form_type":"4"}},{"id":3478218,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":156473,"kind":"organization","name":"Ninth MDV Partners, L.L.C.","position":1,"cik":"0001573991","reported_name":"Ninth MDV Partners, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156474,"kind":"organization","name":"MDV IX LP","position":2,"cik":"0001410787","reported_name":"MDV IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156475,"kind":"organization","name":"MDV ENF IX LP","position":3,"cik":"0001435083","reported_name":"MDV ENF IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135893,"kind":"person","name":"FEIBER JONATHAN D","position":4,"cik":"0001027621","reported_name":"FEIBER JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41306,"kind":"person","name":"Ericson William W.","position":5,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-26T16:54:22.000Z","date":"2019-06-24","kind":"exercise","acquired":true,"shares":18739,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held directly by MDV ENF IX, L.P. (\"ENF IX\"). Ninth MDV is the general partner of ENF IX. Jonathan Feiber and William Ericson are the managing members of Ninth MDV and either are deemed to have sole voting and dispositive power with respect to the shares held by ENF IX. Each disclaims beneficial ownership of these securities except to the extent of his or its respective pecuniary interest therein."}],"balance_after":18739,"source":{"system":"sec-edgar","filing":"0001209191-19-039125","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1027621/000120919119039125/doc4.xml","form_type":"4"}},{"id":3478217,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":156473,"kind":"organization","name":"Ninth MDV Partners, L.L.C.","position":1,"cik":"0001573991","reported_name":"Ninth MDV Partners, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156474,"kind":"organization","name":"MDV IX LP","position":2,"cik":"0001410787","reported_name":"MDV IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156475,"kind":"organization","name":"MDV ENF IX LP","position":3,"cik":"0001435083","reported_name":"MDV ENF IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135893,"kind":"person","name":"FEIBER JONATHAN D","position":4,"cik":"0001027621","reported_name":"FEIBER JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41306,"kind":"person","name":"Ericson William W.","position":5,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-26T16:54:22.000Z","date":"2019-06-24","kind":"exercise","acquired":true,"shares":61592,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by MDV IX, L.P. (\"MDV IX\"). Ninth MDV Partners, L.L.C. (\"Ninth MDV\") is the general partner of MDV IX. Jonathan Feiber and William Ericson are the managing members of Ninth MDV and either are deemed to have sole voting and dispositive power with respect to the shares held by MDV IX. Each disclaims beneficial ownership of these securities except to the extent of his or its respective pecuniary interest therein."}],"balance_after":2458209,"source":{"system":"sec-edgar","filing":"0001209191-19-039125","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1027621/000120919119039125/doc4.xml","form_type":"4"}},{"id":3478216,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":156473,"kind":"organization","name":"Ninth MDV Partners, L.L.C.","position":1,"cik":"0001573991","reported_name":"Ninth MDV Partners, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156474,"kind":"organization","name":"MDV IX LP","position":2,"cik":"0001410787","reported_name":"MDV IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156475,"kind":"organization","name":"MDV ENF IX LP","position":3,"cik":"0001435083","reported_name":"MDV ENF IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135893,"kind":"person","name":"FEIBER JONATHAN D","position":4,"cik":"0001027621","reported_name":"FEIBER JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41306,"kind":"person","name":"Ericson William W.","position":5,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-26T16:54:22.000Z","date":"2019-06-24","kind":"exercise","acquired":true,"shares":107812,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by MDV IX, L.P. (\"MDV IX\"). Ninth MDV Partners, L.L.C. (\"Ninth MDV\") is the general partner of MDV IX. Jonathan Feiber and William Ericson are the managing members of Ninth MDV and either are deemed to have sole voting and dispositive power with respect to the shares held by MDV IX. Each disclaims beneficial ownership of these securities except to the extent of his or its respective pecuniary interest therein."}],"balance_after":2396617,"source":{"system":"sec-edgar","filing":"0001209191-19-039125","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1027621/000120919119039125/doc4.xml","form_type":"4"}},{"id":3478215,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":156473,"kind":"organization","name":"Ninth MDV Partners, L.L.C.","position":1,"cik":"0001573991","reported_name":"Ninth MDV Partners, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156474,"kind":"organization","name":"MDV IX LP","position":2,"cik":"0001410787","reported_name":"MDV IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156475,"kind":"organization","name":"MDV ENF IX LP","position":3,"cik":"0001435083","reported_name":"MDV ENF IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135893,"kind":"person","name":"FEIBER JONATHAN D","position":4,"cik":"0001027621","reported_name":"FEIBER JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41306,"kind":"person","name":"Ericson William W.","position":5,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-26T16:54:22.000Z","date":"2019-06-24","kind":"exercise","acquired":true,"shares":2288805,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock on a 1-for-1 basis immediately upon the closing of the Issuer's initial public offering and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by MDV IX, L.P. (\"MDV IX\"). Ninth MDV Partners, L.L.C. (\"Ninth MDV\") is the general partner of MDV IX. Jonathan Feiber and William Ericson are the managing members of Ninth MDV and either are deemed to have sole voting and dispositive power with respect to the shares held by MDV IX. Each disclaims beneficial ownership of these securities except to the extent of his or its respective pecuniary interest therein."}],"balance_after":2288805,"source":{"system":"sec-edgar","filing":"0001209191-19-039125","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027621/000120919119039125/doc4.xml","form_type":"4"}},{"id":3498564,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-06T16:17:21.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option shares shall vest as follows: 100% of the option shares shall vest on the date 1 year from June 5, 2019, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of such date."}],"balance_after":10000,"derivative":{"exercise_price":4.8,"expiration_date":"2029-06-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-035058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919119035058/doc4.xml","form_type":"4"}},{"id":3901335,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-07T17:04:16.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option shares shall vest as follows: 100% of the option shares shall vest on the date 1 year from June 6, 2018, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of such date."}],"balance_after":10000,"derivative":{"exercise_price":27.98,"expiration_date":"2028-06-05","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-036418","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919118036418/doc4.xml","form_type":"4"}},{"id":3920312,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-23T20:17:47.000Z","date":"2018-05-22","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one year period."}],"balance_after":25000,"derivative":{"exercise_price":2.61,"exercise_date":"2018-06-22","expiration_date":"2028-05-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-18-032583","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000120919118032583/doc4.xml","form_type":"4"}},{"id":4216002,"issuer":{"id":173349,"kind":"organization","name":"Rocket Fuel Inc.","symbol":"FUEL"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-09-06T14:13:53.000Z","date":"2017-09-06","kind":"disposition_to_issuer","acquired":false,"shares":55090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each outstanding option of the Issuer was either (1) cancelled and converted automatically into the right to receive $2.60 per share in cash, (2) cancelled without any cash payment or other consideration, or (3) assumed and converted automatically into the right to receive $2.60 per share in cash, as described in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":2.68,"expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":55090},"source":{"system":"sec-edgar","filing":"0001209191-17-051535","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1477200/000120919117051535/doc4.xml","form_type":"4"}},{"id":4216001,"issuer":{"id":173349,"kind":"organization","name":"Rocket Fuel Inc.","symbol":"FUEL"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-09-06T14:13:53.000Z","date":"2017-09-06","kind":"disposition_to_issuer","acquired":false,"shares":67060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each outstanding option of the Issuer was either (1) cancelled and converted automatically into the right to receive $2.60 per share in cash, (2) cancelled without any cash payment or other consideration, or (3) assumed and converted automatically into the right to receive $2.60 per share in cash, as described in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":2.24,"expiration_date":"2026-06-14","underlying":"Common Stock","underlying_shares":67060},"source":{"system":"sec-edgar","filing":"0001209191-17-051535","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1477200/000120919117051535/doc4.xml","form_type":"4"}},{"id":4216000,"issuer":{"id":173349,"kind":"organization","name":"Rocket Fuel Inc.","symbol":"FUEL"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-09-06T14:13:53.000Z","date":"2017-09-06","kind":"disposition_to_issuer","acquired":false,"shares":17582,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each outstanding option of the Issuer was either (1) cancelled and converted automatically into the right to receive $2.60 per share in cash, (2) cancelled without any cash payment or other consideration, or (3) assumed and converted automatically into the right to receive $2.60 per share in cash, as described in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":8.47,"expiration_date":"2025-06-08","underlying":"Common Stock","underlying_shares":17582},"source":{"system":"sec-edgar","filing":"0001209191-17-051535","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1477200/000120919117051535/doc4.xml","form_type":"4"}},{"id":4215999,"issuer":{"id":173349,"kind":"organization","name":"Rocket Fuel Inc.","symbol":"FUEL"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-09-06T14:13:53.000Z","date":"2017-09-06","kind":"disposition_to_issuer","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each outstanding option of the Issuer was either (1) cancelled and converted automatically into the right to receive $2.60 per share in cash, (2) cancelled without any cash payment or other consideration, or (3) assumed and converted automatically into the right to receive $2.60 per share in cash, as described in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":23.59,"expiration_date":"2024-06-09","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-17-051535","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477200/000120919117051535/doc4.xml","form_type":"4"}},{"id":4215998,"issuer":{"id":173349,"kind":"organization","name":"Rocket Fuel Inc.","symbol":"FUEL"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-09-06T14:13:53.000Z","date":"2017-09-06","kind":"disposition_to_issuer","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each outstanding option of the Issuer was either (1) cancelled and converted automatically into the right to receive $2.60 per share in cash, (2) cancelled without any cash payment or other consideration, or (3) assumed and converted automatically into the right to receive $2.60 per share in cash, as described in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":29,"expiration_date":"2023-09-19","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001209191-17-051535","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477200/000120919117051535/doc4.xml","form_type":"4"}},{"id":4215997,"issuer":{"id":173349,"kind":"organization","name":"Rocket Fuel Inc.","symbol":"FUEL"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-06T14:13:53.000Z","date":"2017-09-06","kind":"disposition_to_issuer","acquired":false,"shares":13905,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each outstanding share of the common stock of the Issuer was converted into the right to receive $2.60 per share in cash, as described in the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-051535","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477200/000120919117051535/doc4.xml","form_type":"4"}},{"id":4257280,"issuer":{"id":116314,"kind":"organization","name":"Coupa Software Inc","symbol":"COUP"},"owners":[{"id":156474,"kind":"organization","name":"MDV IX LP","position":1,"cik":"0001410787","reported_name":"MDV IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156473,"kind":"organization","name":"Ninth MDV Partners, L.L.C.","position":2,"cik":"0001573991","reported_name":"Ninth MDV Partners, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135893,"kind":"person","name":"FEIBER JONATHAN D","position":3,"cik":"0001027621","reported_name":"FEIBER JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41306,"kind":"person","name":"Ericson William W.","position":4,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-07-14T17:27:06.000Z","date":"2017-07-12","kind":"sale","acquired":false,"shares":1662000,"price":31.25,"value":51937500.0,"ownership":{"direct":false,"nature":"MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ninth MDV Partners, L.L.C. is the general partner of MDV IX, L.P., as nominee for MDV IX, L.P. and MDV ENF IX, L.P. (collectively, \"MDV IX\"). William Ericson (\"Ericson\") and Jonathan Feiber (\"Feiber\") are Managing Members of Ninth MDV Partners, L.L.C. Ericson and Feiber may be deemed to share voting and dispositive power over the shares held by MDV IX and disclaim beneficial ownership of the shares held by MDV IX except to the extent of their pecuniary interest therein."}],"balance_after":3986700,"source":{"system":"sec-edgar","filing":"0001209191-17-045231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027621/000120919117045231/doc4.xml","form_type":"4"}},{"id":4280817,"issuer":{"id":173349,"kind":"organization","name":"Rocket Fuel Inc.","symbol":"FUEL"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-06-15T17:42:40.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":55090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option vest on the earlier of (i) the first anniversary of the date of grant, and (ii) the day prior to the date of the Annual Meeting of Stockholders that immediately follows the Annual Meeting of Stockholders at which the option was granted, provided that the reporting person has remained in continuous service as a Director through the applicable date."}],"balance_after":55090,"derivative":{"exercise_price":2.68,"expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":55090},"source":{"system":"sec-edgar","filing":"0001477200-17-000084","document":"wf-form4_149756294536085.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477200/000147720017000084/wf-form4_149756294536085.xml","form_type":"4"}},{"id":4295354,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-02T17:40:51.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option shares shall vest as follows: 100% of the option shares shall vest on the date 1 year from June 1, 2017, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of such date."}],"balance_after":15000,"derivative":{"exercise_price":16.27,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-17-037390","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919117037390/doc4.xml","form_type":"4"}},{"id":4304581,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-25T20:05:16.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one year period."}],"balance_after":25000,"derivative":{"exercise_price":3.81,"exercise_date":"2017-06-24","expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-17-035313","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000120919117035313/doc4.xml","form_type":"4"}},{"id":4348951,"issuer":{"id":116314,"kind":"organization","name":"Coupa Software Inc","symbol":"COUP"},"owners":[{"id":156474,"kind":"organization","name":"MDV IX LP","position":1,"cik":"0001410787","reported_name":"MDV IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156473,"kind":"organization","name":"Ninth MDV Partners, L.L.C.","position":2,"cik":"0001573991","reported_name":"Ninth MDV Partners, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135893,"kind":"person","name":"FEIBER JONATHAN D","position":3,"cik":"0001027621","reported_name":"FEIBER JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41306,"kind":"person","name":"Ericson William W.","position":4,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-20T16:51:44.000Z","date":"2017-04-18","kind":"sale","acquired":false,"shares":1000000,"price":24.05,"value":24050000.0,"ownership":{"direct":false,"nature":"MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were sold by the reporting person as a selling stockholder pursuant to an underwritten public offering by the Issuer. The offering closed on April 18, 2017. The reported sale price reflects the price at which the reporting person sold shares to the underwriters."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ninth MDV Partners, L.L.C. is the general partner of MDV IX, L.P., as nominee for MDV IX, L.P. and MDV ENF IX, L.P. (collectively, \"MDV IX\"). William Ericson (\"Ericson\") and Jonathan Feiber (\"Feiber\") are Managing Members of Ninth MDV Partners, L.L.C. Ericson and Feiber may be deemed to share voting and dispositive power over the shares held by MDV IX and disclaim beneficial ownership of the shares held by MDV IX except to the extent of their pecuniary interest therein."}],"balance_after":5648700,"source":{"system":"sec-edgar","filing":"0001209191-17-027727","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027621/000120919117027727/doc4.xml","form_type":"4"}},{"id":4579750,"issuer":{"id":116314,"kind":"organization","name":"Coupa Software Inc","symbol":"COUP"},"owners":[{"id":156474,"kind":"organization","name":"MDV IX LP","position":1,"cik":"0001410787","reported_name":"MDV IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156473,"kind":"organization","name":"Ninth MDV Partners, L.L.C.","position":2,"cik":"0001573991","reported_name":"Ninth MDV Partners, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135893,"kind":"person","name":"FEIBER JONATHAN D","position":3,"cik":"0001027621","reported_name":"FEIBER JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41306,"kind":"person","name":"Ericson William W.","position":4,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Convertible Preferred Stock","published_at":"2016-10-14T14:34:50.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":86526,"ownership":{"direct":false,"nature":"MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P."},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock and Series F Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering.  The exercisability date and expiration date are not relevant to the conversion of these securities."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock and Series F Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering.  The exercisability date and expiration date are not relevant to the conversion of these securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock and Series F Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering.  The exercisability date and expiration date are not relevant to the conversion of these securities."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock and Series F Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering.  The exercisability date and expiration date are not relevant to the conversion of these securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ninth MDV Partners, L.L.C. is the general partner of MDV IX, L.P., as nominee for MDV IX, L.P. and MDV ENF IX, L.P. (collectively, \"MDV IX\"). William Ericson (\"Ericson\") and Jonathan Feiber (\"Feiber\") are Managing Members of Ninth MDV Partners, L.L.C. Ericson and Feiber may be deemed to share voting and dispositive power over the shares held by MDV IX and disclaim beneficial ownership of the shares held by MDV IX except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":8.09,"underlying":"Common Stock","underlying_shares":86526},"source":{"system":"sec-edgar","filing":"0001209191-16-145895","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1027621/000120919116145895/doc4.xml","form_type":"4"}},{"id":4579749,"issuer":{"id":116314,"kind":"organization","name":"Coupa Software Inc","symbol":"COUP"},"owners":[{"id":156474,"kind":"organization","name":"MDV IX LP","position":1,"cik":"0001410787","reported_name":"MDV IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156473,"kind":"organization","name":"Ninth MDV Partners, L.L.C.","position":2,"cik":"0001573991","reported_name":"Ninth MDV Partners, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135893,"kind":"person","name":"FEIBER JONATHAN D","position":3,"cik":"0001027621","reported_name":"FEIBER JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41306,"kind":"person","name":"Ericson William W.","position":4,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Convertible Preferred Stock","published_at":"2016-10-14T14:34:50.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":1015725,"ownership":{"direct":false,"nature":"MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P."},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock and Series F Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering.  The exercisability date and expiration date are not relevant to the conversion of these securities."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock and Series F Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering.  The exercisability date and expiration date are not relevant to the conversion of these securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock and Series F Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering.  The exercisability date and expiration date are not relevant to the conversion of these securities."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock and Series F Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering.  The exercisability date and expiration date are not relevant to the conversion of these securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ninth MDV Partners, L.L.C. is the general partner of MDV IX, L.P., as nominee for MDV IX, L.P. and MDV ENF IX, L.P. (collectively, \"MDV IX\"). William Ericson (\"Ericson\") and Jonathan Feiber (\"Feiber\") are Managing Members of Ninth MDV Partners, L.L.C. Ericson and Feiber may be deemed to share voting and dispositive power over the shares held by MDV IX and disclaim beneficial ownership of the shares held by MDV IX except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":3.1148,"underlying":"Common Stock","underlying_shares":1015725},"source":{"system":"sec-edgar","filing":"0001209191-16-145895","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1027621/000120919116145895/doc4.xml","form_type":"4"}},{"id":4579748,"issuer":{"id":116314,"kind":"organization","name":"Coupa Software Inc","symbol":"COUP"},"owners":[{"id":156474,"kind":"organization","name":"MDV IX LP","position":1,"cik":"0001410787","reported_name":"MDV IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156473,"kind":"organization","name":"Ninth MDV Partners, L.L.C.","position":2,"cik":"0001573991","reported_name":"Ninth MDV Partners, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135893,"kind":"person","name":"FEIBER JONATHAN D","position":3,"cik":"0001027621","reported_name":"FEIBER JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41306,"kind":"person","name":"Ericson William W.","position":4,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2016-10-14T14:34:50.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":5546449,"ownership":{"direct":false,"nature":"MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P."},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock and Series F Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering.  The exercisability date and expiration date are not relevant to the conversion of these securities."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock and Series F Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering.  The exercisability date and expiration date are not relevant to the conversion of these securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock and Series F Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering.  The exercisability date and expiration date are not relevant to the conversion of these securities."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock and Series F Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering.  The exercisability date and expiration date are not relevant to the conversion of these securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ninth MDV Partners, L.L.C. is the general partner of MDV IX, L.P., as nominee for MDV IX, L.P. and MDV ENF IX, L.P. (collectively, \"MDV IX\"). William Ericson (\"Ericson\") and Jonathan Feiber (\"Feiber\") are Managing Members of Ninth MDV Partners, L.L.C. Ericson and Feiber may be deemed to share voting and dispositive power over the shares held by MDV IX and disclaim beneficial ownership of the shares held by MDV IX except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":1.3524,"underlying":"Common Stock","underlying_shares":5546449},"source":{"system":"sec-edgar","filing":"0001209191-16-145895","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1027621/000120919116145895/doc4.xml","form_type":"4"}},{"id":4579747,"issuer":{"id":116314,"kind":"organization","name":"Coupa Software Inc","symbol":"COUP"},"owners":[{"id":156474,"kind":"organization","name":"MDV IX LP","position":1,"cik":"0001410787","reported_name":"MDV IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156473,"kind":"organization","name":"Ninth MDV Partners, L.L.C.","position":2,"cik":"0001573991","reported_name":"Ninth MDV Partners, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135893,"kind":"person","name":"FEIBER JONATHAN D","position":3,"cik":"0001027621","reported_name":"FEIBER JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41306,"kind":"person","name":"Ericson William W.","position":4,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-14T14:34:50.000Z","date":"2016-10-12","kind":"exercise","acquired":true,"shares":6648700,"ownership":{"direct":false,"nature":"MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock and Series F Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock for no additional consideration immediately prior to the completion of the Issuer's initial public offering.  The exercisability date and expiration date are not relevant to the conversion of these securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ninth MDV Partners, L.L.C. is the general partner of MDV IX, L.P., as nominee for MDV IX, L.P. and MDV ENF IX, L.P. (collectively, \"MDV IX\"). William Ericson (\"Ericson\") and Jonathan Feiber (\"Feiber\") are Managing Members of Ninth MDV Partners, L.L.C. Ericson and Feiber may be deemed to share voting and dispositive power over the shares held by MDV IX and disclaim beneficial ownership of the shares held by MDV IX except to the extent of their pecuniary interest therein."}],"balance_after":6648700,"source":{"system":"sec-edgar","filing":"0001209191-16-145895","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027621/000120919116145895/doc4.xml","form_type":"4"}},{"id":4601305,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-09-16T20:24:36.000Z","date":"2016-09-16","kind":"purchase","acquired":true,"shares":8240,"price":16.8079,"value":138497.096,"ownership":{"direct":false,"nature":"MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Price reflected is the weighted-average purchase price for shares purchased. The range of the purchase prices for the transaction was $16.52 and $17.00 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV ENF VII(A), L.P., MDV ENF VII(B), L.P., and MDV VII Leaders' Fund, L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII(A), L.P., (iv) MDV ENF VII(B), L.P., and (v) MDV VII Leaders' Fund, L.P. (collectively, \"MDV VII\"). Feiber and Nancy Schoendorf (\"Schoendorf\") are Managing Members of Seventh MDV Partners, L.L.C. Feiber and Schoendorf may be deemed to share voting and dispositive power over the shares held by MDV VII. Each Reporting Person disclaims beneficial ownership of the shares held by MDV VII except to the extent of any pecuniary interest therein. Ericson, a general partner with Mohr Davidow Ventures, may be deemed to indirectly beneficially own the shares affiliated with MDV VII. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":4031804,"source":{"system":"sec-edgar","filing":"0001209191-16-141890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919116141890/doc4.xml","form_type":"4"}},{"id":4601304,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-09-16T20:24:36.000Z","date":"2016-09-15","kind":"purchase","acquired":true,"shares":200,"price":16.5,"value":3300.0,"ownership":{"direct":false,"nature":"MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV ENF VII(A), L.P., MDV ENF VII(B), L.P., and MDV VII Leaders' Fund, L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII(A), L.P., (iv) MDV ENF VII(B), L.P., and (v) MDV VII Leaders' Fund, L.P. (collectively, \"MDV VII\"). Feiber and Nancy Schoendorf (\"Schoendorf\") are Managing Members of Seventh MDV Partners, L.L.C. Feiber and Schoendorf may be deemed to share voting and dispositive power over the shares held by MDV VII. Each Reporting Person disclaims beneficial ownership of the shares held by MDV VII except to the extent of any pecuniary interest therein. Ericson, a general partner with Mohr Davidow Ventures, may be deemed to indirectly beneficially own the shares affiliated with MDV VII. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":4023564,"source":{"system":"sec-edgar","filing":"0001209191-16-141890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919116141890/doc4.xml","form_type":"4"}},{"id":4601303,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-09-16T20:24:36.000Z","date":"2016-09-14","kind":"purchase","acquired":true,"shares":54537,"price":16.4253,"value":895786.5861,"ownership":{"direct":false,"nature":"MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Price reflected is the weighted-average purchase price for shares purchased. The range of the purchase prices for the transaction was $16.22 and $16.50 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV ENF VII(A), L.P., MDV ENF VII(B), L.P., and MDV VII Leaders' Fund, L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII(A), L.P., (iv) MDV ENF VII(B), L.P., and (v) MDV VII Leaders' Fund, L.P. (collectively, \"MDV VII\"). Feiber and Nancy Schoendorf (\"Schoendorf\") are Managing Members of Seventh MDV Partners, L.L.C. Feiber and Schoendorf may be deemed to share voting and dispositive power over the shares held by MDV VII. Each Reporting Person disclaims beneficial ownership of the shares held by MDV VII except to the extent of any pecuniary interest therein. Ericson, a general partner with Mohr Davidow Ventures, may be deemed to indirectly beneficially own the shares affiliated with MDV VII. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":4023364,"source":{"system":"sec-edgar","filing":"0001209191-16-141890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919116141890/doc4.xml","form_type":"4"}},{"id":4603123,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-09-14T19:03:52.000Z","date":"2016-09-13","kind":"purchase","acquired":true,"shares":62034,"price":15.5559,"value":964994.7006,"ownership":{"direct":false,"nature":"MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Price reflected is the weighted-average sale price for shares sold. The range of the sale prices for the transaction was $15.25 and $16.00 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV ENF VII(A), L.P., MDV ENF VII(B), L.P., and MDV VII Leaders' Fund, L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII(A), L.P., (iv) MDV ENF VII(B), L.P., and (v) MDV VII Leaders' Fund, L.P. (collectively, \"MDV VII\"). Feiber and Nancy Schoendorf (\"Schoendorf\") are Managing Members of Seventh MDV Partners, L.L.C. Feiber and Schoendorf may be deemed to share voting and dispositive power over the shares held by MDV VII. Each Reporting Person disclaims beneficial ownership of the shares held by MDV VII except to the extent of any pecuniary interest therein. Ericson, a general partner with Mohr Davidow Ventures, may be deemed to indirectly beneficially own the shares affiliated with MDV VII. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":3968827,"source":{"system":"sec-edgar","filing":"0001209191-16-141472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919116141472/doc4.xml","form_type":"4"}},{"id":4603122,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-09-14T19:03:52.000Z","date":"2016-09-12","kind":"purchase","acquired":true,"shares":22342,"price":15.6537,"value":349734.9654,"ownership":{"direct":false,"nature":"MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Price reflected is the weighted-average sale price for shares sold. The range of the sale prices for the transaction was $15.26 and $15.75 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV ENF VII(A), L.P., MDV ENF VII(B), L.P., and MDV VII Leaders' Fund, L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII(A), L.P., (iv) MDV ENF VII(B), L.P., and (v) MDV VII Leaders' Fund, L.P. (collectively, \"MDV VII\"). Feiber and Nancy Schoendorf (\"Schoendorf\") are Managing Members of Seventh MDV Partners, L.L.C. Feiber and Schoendorf may be deemed to share voting and dispositive power over the shares held by MDV VII. Each Reporting Person disclaims beneficial ownership of the shares held by MDV VII except to the extent of any pecuniary interest therein. Ericson, a general partner with Mohr Davidow Ventures, may be deemed to indirectly beneficially own the shares affiliated with MDV VII. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":3906793,"source":{"system":"sec-edgar","filing":"0001209191-16-141472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919116141472/doc4.xml","form_type":"4"}},{"id":4606594,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-09-09T19:24:25.000Z","date":"2016-09-07","kind":"purchase","acquired":true,"shares":60846,"price":15.68,"value":954065.28,"ownership":{"direct":false,"nature":"MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Price reflected is the weighted-average sale price for shares sold. The range of the sale prices for the transaction was $15.25 and $15.81 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV ENF VII(A), L.P., MDV ENF VII(B), L.P., and MDV VII Leaders' Fund, L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII(A), L.P., (iv) MDV ENF VII(B), L.P., and (v) MDV VII Leaders' Fund, L.P. (collectively, \"MDV VII\"). Feiber and Nancy Schoendorf (\"Schoendorf\") are Managing Members of Seventh MDV Partners, L.L.C. Feiber and Schoendorf may be deemed to share voting and dispositive power over the shares held by MDV VII. Each Reporting Person disclaims beneficial ownership of the shares held by MDV VII except to the extent of any pecuniary interest therein. Ericson, a general partner with Mohr Davidow Ventures, may be deemed to indirectly beneficially own the shares affiliated with MDV VII. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":3884451,"source":{"system":"sec-edgar","filing":"0001209191-16-140845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919116140845/doc4.xml","form_type":"4"}},{"id":4609202,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-09-07T20:40:51.000Z","date":"2016-09-06","kind":"purchase","acquired":true,"shares":7200,"price":14.9972,"value":107979.84,"ownership":{"direct":false,"nature":"MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Price reflected is the weighted-average sale price for shares sold. The range of the sale prices for the transaction was $14.70 and $15.23 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV ENF VII(A), L.P., MDV ENF VII(B), L.P., and MDV VII Leaders' Fund, L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII(A), L.P., (iv) MDV ENF VII(B), L.P., and (v) MDV VII Leaders' Fund, L.P. (collectively, \"MDV VII\"). Feiber and Nancy Schoendorf (\"Schoendorf\") are Managing Members of Seventh MDV Partners, L.L.C. Feiber and Schoendorf may be deemed to share voting and dispositive power over the shares held by MDV VII. Each Reporting Person disclaims beneficial ownership of the shares held by MDV VII except to the extent of any pecuniary interest therein. Ericson, a general partner with Mohr Davidow Ventures, may be deemed to indirectly beneficially own the shares affiliated with MDV VII. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":3823605,"source":{"system":"sec-edgar","filing":"0001209191-16-140474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919116140474/doc4.xml","form_type":"4"}},{"id":4609201,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":41306,"kind":"person","name":"Ericson William W.","position":1,"cik":"0001503381","reported_name":"Ericson William W.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-09-07T20:40:51.000Z","date":"2016-09-02","kind":"purchase","acquired":true,"shares":43719,"price":14.7515,"value":644920.8285,"ownership":{"direct":false,"nature":"MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Price reflected is the weighted-average sale price for shares sold. The range of the sale prices for the transaction was $14.54 and $15.00 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV ENF VII(A), L.P., MDV ENF VII(B), L.P., and MDV VII Leaders' Fund, L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII(A), L.P., (iv) MDV ENF VII(B), L.P., and (v) MDV VII Leaders' Fund, L.P. (collectively, \"MDV VII\"). Feiber and Nancy Schoendorf (\"Schoendorf\") are Managing Members of Seventh MDV Partners, L.L.C. Feiber and Schoendorf may be deemed to share voting and dispositive power over the shares held by MDV VII. Each Reporting Person disclaims beneficial ownership of the shares held by MDV VII except to the extent of any pecuniary interest therein. Ericson, a general partner with Mohr Davidow Ventures, may be deemed to indirectly beneficially own the shares affiliated with MDV VII. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":3816405,"source":{"system":"sec-edgar","filing":"0001209191-16-140474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1328143/000120919116140474/doc4.xml","form_type":"4"}}]}